Celadon Pharmaceuticals (LSE:CEL) Total Tax Payable : €0.10 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Total Tax Payable?

Celadon Pharmaceuticals's Total Tax Payable for the quarter that ended in Dec. 2023 was €0.10 Mil.

Celadon Pharmaceuticals's quarterly Total Tax Payable declined from Dec. 2022 (€0.11 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.10 Mil).

Celadon Pharmaceuticals's annual Total Tax Payable increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.11 Mil) but then declined from Dec. 2022 (€0.11 Mil) to Dec. 2023 (€0.10 Mil).

Celadon Pharmaceuticals Total Tax Payable Historical Data

The historical data trend for Celadon Pharmaceuticals's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Total Tax Payable Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

0.11

0.10

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Tax Payable	Get a 7-Day Free Trial			-	-	0.11	-	0.10

Celadon Pharmaceuticals Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Celadon Pharmaceuticals Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines